Related Experiment Videos
Calcium antagonists and atherosclerosis
Abstract:
Numerous trials have used calcium antagonistic substances to inhibit or prevent genesis and progression of atherosclerosis, as well as disintegration of intimal proliferates and calcium deposition in atheromas or in matrix tissue of artery walls. In experimental models, various components involved in the development of atherosclerosis can be influenced by calcium antagonists. Transendothelial transport through interendothelial spaces and through the endothelial cells are sensitive to calcium antagonists of various types. Some drugs with calcium antagonistic properties are capable of inhibiting the development of stenosing proliferates caused by ballooning or other types of local artery wall stimulation. With cultures of cells obtained from normal and atherosclerotic arteries, insights into the mechanisms are possible by which various calcium antagonists influence the development and the progression of atherosclerosis.
Insights
Calcium antagonists show promise in preventing atherosclerosis progression and reducing arterial plaque. These substances impact key mechanisms, including endothelial transport and cell proliferation, offering therapeutic potential.
Area of Science:
- Cardiovascular Research
- Pharmacology
- Atherosclerosis Pathogenesis
Background:
- Atherosclerosis is a chronic inflammatory disease characterized by plaque buildup in arteries.
- Calcium plays a critical role in vascular smooth muscle contraction and endothelial function.
- Existing research explores calcium's involvement in atheroma formation and progression.
Purpose of the Study:
- To investigate the role of calcium antagonists in preventing atherosclerosis.
- To explore the impact of calcium antagonists on intimal hyperplasia and calcium deposition.
- To understand how calcium antagonists affect endothelial transport and cell proliferation in atherosclerosis.
Main Methods:
- Review of numerous clinical trials and experimental models investigating calcium antagonists.
- Analysis of studies focusing on transendothelial transport mechanisms.
- In vitro studies using cell cultures from normal and atherosclerotic arteries.
Main Results:
- Calcium antagonists demonstrate potential in inhibiting atherosclerosis genesis and progression.
- These agents can influence atheroma calcification and intimal proliferation.
- Transendothelial transport and endothelial cell functions are sensitive to various calcium antagonists.
- Calcium antagonists can inhibit stenotic lesion development following arterial stimulation.
Conclusions:
- Calcium antagonists represent a potential therapeutic strategy for managing atherosclerosis.
- Further research into the mechanisms of calcium antagonists is warranted for effective treatment.
- Targeting calcium pathways offers a promising avenue for cardiovascular disease intervention.